Xiaojian Yan1 article listing Xiaojian Yan in Nature Communications, indexed by Paperzzz from Crossref and OSF.Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial Nature Communications